Business
– Chaim Hurvitz and Dan Suesskind will step down and Chairman Phillip Frost will leave before the end of the year. – – Chaim...
Hi, what are you looking for?
– Chaim Hurvitz and Dan Suesskind will step down and Chairman Phillip Frost will leave before the end of the year. – – Chaim...
– Bristol-Myers Squibb’s Baraclude has $314 million in US annual sales. – – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that the U.S. Court...
– Eyal Desheh: There are many small US companies developing complex generic products. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is eying small acquisitions...
– Yao Fang: We’ve already begun due diligence on several Israeli medical devices companies. – – Shanghai Fosun Pharmaceutical Group Co. Ltd. (SHE: 600196;...
– Jiangsu NHWA Pharmaceutical is developing DP-VPA in China under a strategic agreement. – D-Pharm Ltd. (TASE: DPRM) has obtained fast track status from the China’s...
– Enabling the Global Integration of the Company and Positioning It for Short- and Long-Term Value Creation. – – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; TASE: TEVA)...
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Teva Pharmaceutical...
– – Israeli biomedical firms look back on a successful year on Wall Street. Are we bearing witness to “the new tech”? Will the...
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...
– The Phase III trial results showed significant improvement in the treatment of chronic low back pain. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...